Financial insights of PCRX

MyFinsight

For the quarter ending 2026-03-31.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Goodwill impairment	-	0	0	-
Total revenues	177,376	196,873	179,516	181,099
Cost of goods sold (exclusive of amortization of acquired intangible assets)	36,413	40,299	34,278	40,866
Contingent consideration gains, acquisition-related expenses, restructuring and other	-	500	6,791	634
Research and development	28,072	37,804	25,966	28,200
Selling, general and administrative	93,944	101,608	91,797	88,578
Amortization of acquired intangible assets	14,322	14,322	14,322	14,322
Other operating (gains) expenses, net	2,277	-	-	-
Total operating expenses	170,474	194,533	173,154	172,600
Income from operations	6,902	2,340	6,362	8,499
Interest income	1,930	2,295	8,534	5,008
Interest expense	3,699	3,892	4,279	4,695
(gain) loss on early extinguishment of debt	-	0	-983	0
Other, net	-135	-172	-110	-10,739
Total other (expense) income, net	-1,904	-1,769	3,162	-10,426
Income before income taxes	4,998	571	9,524	-1,927
Income tax expense	2,082	-1,066	4,092	2,920
Net income	2,916	1,637	5,432	-4,847

Basic EPS	0.07	0.039	0.12	-0.11
Diluted EPS	0.07	0.037	0.12	-0.11
Basic Average Shares	40,461,000	42,492,000	44,038,000	45,459,000
Diluted Average Shares	40,910,000	43,724,000	44,459,000	45,459,000

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.